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Abstract. Cortical sources of resting eyes-closed alpha rhythms are typically abnormal in mild cognitive impairment (MCI) and
Alzheimer’s disease (AD) subjects. Here we tested the hypothesis of a progressive impairment of cortical alpha reactivity to eye-
opening across amnesic MCI and mild AD subjects, reflecting another aspect of the impairment of cortical neural synchronization.
Resting electroencephalography (EEG) data were recorded in 36 normal elderly subjects (Nold), 91 amnesic MCI, and 31 mild
AD subjects during eyes-closed and -open conditions. EEG sources were estimated by LORETA software. In the eye-closed
condition, posterior alpha 1 (8–10.5 Hz) sources were lower in MCI and AD than Nold subjects. The opposite was true for
occipital delta sources (2–4 Hz). Reactivity to the eyes-open condition showed posterior alpha 1 and alpha 2 (10.5–13 Hz) sources
was high in the Nold, intermediate in the MCI, and low in the AD subjects. Furthermore, occipital alpha 1 reactivity across MCI
and AD subjects was correlated to the cognitive impairment as revealed by Mini-Mental State Examination score. In conclusion,
at least at group level, the continuum across amnesic MCI and mild AD status is related to an impaired reactivity of cortical
neuronal synchronization to eyes opening at alpha rhythms.
Keywords: Alzheimer’s disease, amnesic mild cognitive impairment, delta, theta, and alpha rhythms, electroencephalography,
eyes-closed resting state, eyes-open resting state, low resolution brain electromagnetic tomography (LORETA)
INTRODUCTION
Mild cognitive impairment (MCI) is a clinical state
between elderly normal cognition and dementia, featur-
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Foggia, Italy. Tel.: +39 0881 713276; Fax: +39 0881 711716;
E-mail: c.babiloni@unifg.it.
ing memory complaints and cognitive impairment on
neuropsychological testing not yet fulfilling the clinical
picture of dementia [1–3]. Amnesic MCI is regarded
as a precursor of Alzheimer’s disease (AD) [4–6] since
recent studies have shown a high rate of progression
to AD [3,7,8]. In cognitively intact elderly subjects,
the incidence of AD ranges from 0.17 to 3.86% [3,
9], while in amnesic MCI subjects it ranges from 6 to
25% [3]. However, the “transition” hypothesis is chal-
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lenged by observations indicating that not all MCI sub-
jects deteriorate over time [10,11], as AD cumulative
incidence rates range from 40 to 60% [10–12]. These
data motivate investigations aimed at understanding the
neurobiological basis of MCI condition, in order to re-
fine diagnostic/prognostic procedures and to target new
pharmacological interventions [13–16].
To evaluate the general mechanisms of cortical neu-
ral synchronization in MCI and AD conditions, the
power of resting-state (“resting”) eyes-closed elec-
troencephalographic (EEG) rhythms has been evaluat-
ed. When compared to healthy elderly (Nold) subjects,
AD patients have been characterized by high power of
delta (0–4 Hz) and theta (4–7 Hz) rhythms, and low
power of posterior alpha (8–12 Hz) and/or beta (13–
30 Hz) rhythms [17–23]. Furthermore, posterior al-
pha rhythms have shown a power decrement in MCI
compared to Nold subjects [19,23–27], and have been
related to the risk of progression to AD [28]. Fine to-
pography of these rhythms has been specified by the
magnetoencephalographic (MEG) counterpart of EEG
activity [28,29]. However, a certain variability of rest-
ing eyes-closed brain rhythmicity in pathological aging
might limit its practical utility for personalized diagno-
sis and prognosis, especially at earlier stages of MCI
condition. For example, recent high-resolution mag-
netoencephalographic evidence has shown no statisti-
cally significant difference of brain rhythms in normal
elderly and MCI subjects [30].
To obtain more informative data on cortical neural
synchronization, resting alpha rhythms have been eval-
uated by comparing EEG or MEG oscillations collect-
ed in eyes-closed and -open conditions. Previous EEG
studies have repeatedly reported a poor suppression (re-
activity) of alpha power during eye opening in AD com-
pared with Nold subjects [21,31–33]. This lack of reac-
tivity has been also used to predict the long term dete-
rioration of higher functions in subjects with cognitive
decline [34]. Furthermore, MEG studies have shown
that compared with Nold subjects, AD patients were
characterized both by lower occipital and temporal al-
pha power in the eyes-closed condition and by lower
reactivity of alpha rhythms during eye opening [35].
In only one previous EEG study, alpha rhythms to
the eyes opening have been compared among Nold,
MCI, and AD subjects [33]. The results showed sta-
tistically significant differences between Nold and AD
(p < 0.05) but not between MCI and AD subjects [33].
MEG studies have also shown that posterior sources of
alpha rhythms were lower in power during eyes-open
compared with-closed conditions in Nold, MCI, and
AD subjects, and that the reactivity of alpha rhythms
was greater in the Nold than AD subjects; again, no
difference in reactivity was observed between MCI and
AD subjects [36]. This lack of difference in the men-
tioned EEG and MEG studies might be due to some
reasons. On one hand, previous evidence might lead
support to the idea that cortical neural mechanisms at
the basis of eyes opening are normal in MCI subjects.
On the other hand, the lack of EEG differences might
be due to the use of relatively small groups and/or high
inter-subjects variability of neurodegenerative process-
es in MCI subjects. These reasons may also explain
MEG evidence showing no statistically significant dif-
ference of resting eyes-closed brain rhythms in Nold
and MCI subjects [30].
To gain statistical power and sensitivity, we have re-
cently proposed a methodological approach including
the use of large groups of MCI or AD subjects, cheap
digital EEG recordings, and regional source analysis of
EEG rhythms by a popular called low resolution brain
electromagnetic tomography (LORETA) that takes into
account the head volume conduction effects and can
be downloaded from Internet towards extensive clinical
applications [37]. Thanks to this approach, we have
shown progressive differences of resting cortical alpha
rhythms along Nold, amnesic MCI, and mild AD sub-
jects [27,28,38,39]. In the present study, we applied
the methodological approach mentioned above to test
the hypothesis of a progressive impairment of corti-
cal alpha reactivity to eye opening across Nold, am-
nesic MCI, and AD subjects. Therefore, this study ex-
plores another aspect of the impairment of cortical neu-
ral desynchronization with respect to the mechanisms
of cortical neural synchronization associated to the con-
dition of eyes closed resting state, the latter being in-
vestigated by a bulk of previous EEG studies of the
Consortium formed by the present Authors’ research
groups [27,28,38,39]. As a novelty, here we evaluat-
ed topographical reactivity of alpha rhythms to eyes
opening among relatively large groups of Nold, am-
nesic MCI, and mild AD subjects, in order to conclu-
sively ascertain if this reactivity is normal or abnormal
at group level in the grey zone between preclinical and
clinical stages of AD. At this early stage of the research,
we focused on the group analysis as a basis of future
longitudinal investigations on the practical diagnostic
or prognostic utility of the present methodological ap-
proach at single subject level. Noteworthy, amnesic
MCI status is not necessary the precursor of AD, and
AD, with its specific neuropathological alterations, can
be a qualitatively different state from the others.
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METHODS
Subjects and diagnostic criteria
In this study, we recruited 91 amnesic MCI subjects
and 31 AD patients. Local institutional ethics com-
mittees approved the study. All experiments were per-
formed with the informed and overt consent of each par-
ticipant or caregiver, in line with the Code of Ethics of
the World Medical Association (Declaration of Helsin-
ki) and the standards established by the Author’s Insti-
tutional Review Board.
The present inclusion and exclusion criteria for am-
nesic MCI subjects were based on previous seminal re-
ports [1–3,40–45]. Summarizing, the inclusion crite-
ria were as follows: (i) objective memory impairment
on neuropsychological evaluation, as defined by per-
formances > 1.5 standard deviation below the mean
value of age- and education-matched controls for a bat-
tery of neuropsychological tests, to assess cognitive
performance in the domains of memory (i.e., Busckhe-
Fuld and Memory Rey tests), language, executive func-
tion/attention, and visuo-construction [46–56]; (ii) nor-
mal activities of daily living as documented by the his-
tory and evidence of independent living [57]; and (iii)
clinical dementia rating score of 0.5 [58]. The exclu-
sion criteria included: (i) mild AD, as diagnosed by
standard protocols including NINCDS-ADRDA [59];
(ii) evidence (including magnetic resonance imaging
(MRI) procedures) of concomitant dementia such as
frontotemporal, vascular dementia, reversible demen-
tias (including pseudo-depressive dementia), marked
fluctuations in cognitive performance compatible with
Lewy body dementia and/or features of mixed de-
mentias; (iii) evidence of concomitant extra-pyramidal
symptoms; (iv) clinical and indirect evidence of de-
pression as revealed by the Geriatric Depression Scale
(GDS; [60]) scores lower than 14 (no depression); (v)
other psychiatric diseases, epilepsy, drug addiction, al-
cohol dependence (as revealed by a psychiatric inter-
view), and use of psychoactive drugs including acetyl-
cholinesterase inhibitors or other drugs enhancing brain
cognitive functions; and (vi) current or previous un-
controlled or complicated systemic diseases (including
diabetes mellitus) or traumatic brain injuries.
A battery of neuropsychological tests was performed
to assess cognitive performance in the domains of mem-
ory, language, executive function/attention, and visuo-
construction abilities in MCI and AD. The tests to as-
sess memory were the immediate and delayed recall
measure of the Rey Auditory Verbal Learning Test [48,
49], the delayed recall of Rey figures [50], the delayed
recall of a 3-word list [51], and the delayed recall of
a story [52]. The tests to assess language were the
1-minute verbal fluency for letters [53], the 1-minute
verbal fluency for fruits, animals or car trades [53], and
the Token test [52,54]. The tests to assess executive
function and attention were the Trail Making Test part
A and B [55], the attentive matrices [52], the Digit for-
ward, and the Digit backward [56]. Finally, the tests
to assess visuo-construction were the copy of Rey fig-
ures [50], the Raven of Progressive matrices [46], and
the Clock Drawing test [47].
Probable AD was diagnosed according to NINCDS-
ADRDA [59] and DSM IV criteria. The recruited
AD patients underwent general medical, neurological,
and psychiatric assessments. Patients were also rated
with a number of standardized diagnostic and severi-
ty instruments that included Mini-Mental State Evalu-
ation (MMSE; [61]), Clinical Dementia Rating Scale
(CDR; [58]), GDS [60], Hachinski Ischemic Score
(HIS, [62]), and Instrumental Activities of Daily Liv-
ing scale (IADL, [57]). Neuroimaging diagnostic pro-
cedures (MRI) and complete laboratory analyses were
carried out to exclude other causes of progressive or
reversible dementias, in order to have a clinically ho-
mogenous mild AD group. Exclusion criteria includ-
ed any evidence of: (i) frontotemporal dementia, di-
agnosed according to criteria of Lund and Manchester
Groups (1994), (ii) vascular dementia, diagnosed ac-
cording to NINDS-AIREN criteria [63], (iii) extra-
pyramidal syndromes, (iv) reversible dementias (in-
cluding pseudodementia of depression); and (v) Lewy
body dementia, according to the criteria by McKei-
th [64].
Benzodiazepines, antidepressant, and/or antihyper-
tensive drugs (when present) were withdrawn for about
24 h before the EEG recordings, in order to pair the
period from the last assumption of the drugs and EEG
recording across the MCI and AD subjects (i.e., note
that the effects of drugs discontinuation are typically
observed after longer periods).
For the purposes of this study, we used resting eyes-
closed EEG data of 36 Nold subjects taken from a lo-
cal archive. The Nold subjects were recruited mostly
among non-consanguineous patients’ relatives and un-
derwent physical and neurological examinations as well
as cognitive screening. Subjects affected by chronic
systemic illnesses, those receiving psychoactive drugs,
or with a history of neurological or psychiatric disease
were excluded. All Nold subjects had a GDS score
lower than 14 (no depression).
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Table 1
Demographic and neuropsychological data of healthy elderly (Nold), mild cognitive
impairment (MCI), and mild Alzheimer’s disease (AD) subjects
Nold MCI AD
N 36 91 31
Age (years) 63.9 (± 2.8 SE) 70.6 (± 0.4 SE) 70.5 (± 1.8 SE)
Education (years) 9.7 (± 0.8 SE) 7.3 (± 0.4 SE) 6.5 (± 0.6 SE)
MMSE 28.24 (± 0.25 SE) 26.05 (± 0.23 SE) 21.16 (± 0.75 SE)
IAF 9.4 (± 0.19 SE) 9.4 (± 0.13 SE) 9.0 (± 0.23 SE)
Male/Female 14/22 33/59 7/24
Table 2
Results of neuropsychological tests of interest in the MCI and AD groups. The p value
of the statistical ANOVA comparison is reported
MCI AD MCI vs AD
Rey list immediate recall 32.72 (± 1.26 SE) 16.44 (± 1.71 SE) p < 0.001
Rey list delayed recall 5.98 (± 0.44 SE) 0.83 (± 0.34 SE) p < 0.001
Figure Rey list recall 9.24 (± 0.80 SE) 1.27 (± 0.57SE) p < 0.001
Delayed recall of 3 words (object) 2.78 (± 0.05 SE) 1.33 (± 0.21 SE) p < 0.001
Delayed recall of 3 words (place) 2.84 (± 0.06 SE) 1.62 (± 0.24 SE) p < 0.001
Delayed recall of 3 words (coupling) 2.49 (± 0.11 SE) 0.91 (± 0.22 SE) p < 0.001
Verbal fluency for letter 25.59 (± 1.15 SE) 19.30 (± 1.94 SE) p < 0.005
Verbal fluency for category 27.07 (± 0.95 SE) 17.37 (± 1.62 SE) p < 0.001
Token test 31.50 (± 0.45 SE) 27.45 (± 1.13 SE) p < 0.001
Figure Rey copy 28.79 (± 0.88 SE) 15.25 (± 2.22 SE) p < 0.001
Table 1 reports demographic and neuropsychological
data of Nold, MCI, and AD subjects. Table 2 reports the
score to some neuropsychological tests of interest in the
MCI and AD groups as well as the relative statistically
significant differences (p < 0.05). As expected, the
score of the neuropsychological tests was worse in the
AD group than in the MCI group.
EEG recordings
EEG recordings were performed by specialized clin-
ical units in dimly light rooms in the late morning. Dur-
ing EEG recording, subjects seated on a comfortable
reclined chair. EEG data were collected (0.3–70 Hz
bandpass; cephalic reference) from 19 electrodes po-
sitioned according to the International 10–20 System
(i.e., Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz, C4, T4,
T5, P3, Pz, P4, T6, O1, O2) during standard resting
state eyes-closed and eyes-open conditions. To mon-
itor eye movements, the horizontal and vertical elec-
trooculogram (0.3–70 Hz bandpass) was also collect-
ed. All data were digitized in a continuous recording
mode (5 min of EEG eyes-closed and 5 min of EEG
eyes-open; 128–256 Hz sampling rate). In order to
keep constant the level of vigilance, the experimenters
controlled on-line the subject and the EEG traces. Per-
sonnel of recording units were familiar with the issue
of vigilance in resting state elderly subjects. Experi-
menters verbally alerted the subject any time that be-
havioral and/or EEG drowsiness appeared, especially
during the eyes-closed condition.
The EEG data were analyzed and fragmented off-
line in consecutive epochs of 2 s. The EEG epochs
with ocular, muscular, and other types of artifact were
preliminarily identified by a computerized automatic
procedure. EEG epochs with sporadic blinking arti-
facts (less than 10% of the total) were corrected by an
autoregressive method [65]. Two independent exper-
imenters, blind to the diagnosis, manually confirmed
the EEG segments accepted for further analysis.
Spectral analysis of the EEG data
The digital FFT-based power spectrum analysis
(Welch technique, Hanning windowing function, no
phase shift) was calculated in order to establish the
individual alpha frequency (IAF) peak, defined as the
frequency associated to the maximum power of resting
EEG rhythms at the extended alpha range of 6-14 Hz.
For this purpose, we strictly followed the procedure
for the computation of IAF as originally proposed by
Klimesch’s group, which tested such procedure in sev-
eral validation studies (for a review, see [66]). Specif-
ically, IAF peak was detected on the individual EEG
power spectrum obtained averaging the EEG power
spectral of all scalp electrodes [66]. Mean IAF peak
was 9.4 Hz (±0.19 standard error, SE) in the Nold
subjects, 9.4 Hz (±0.13 SE) in the MCI subjects, and
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9.0 Hz (±0.23 SE) in the AD subjects (Table 1). No
statistically significant ANOVA difference was found
among the groups. Although the subjects’ groups were
characterized by quite similar mean IAF peaks, this
value was used as a covariate (together with age, edu-
cation, gender and resting eyes-closed alpha rhythms)
in the statistics. This allowed the removal of any possi-
ble residual confounding effects on the cortical sources
of alpha rhythms in the comparison among the Nold,
MCI, and AD groups. Indeed, the IAF is a frequency
of special importance, since it is associated with maxi-
mum power of resting eyes-closed EEG rhythms [66].
The above procedure minimized the possibility that
small differences in the IAF peak could confound the
comparisons of cortical alpha sources among the Nold,
MCI, and AD groups.
The frequency bands of interest were delta (2–4 Hz),
theta (4–8 Hz), alpha 1 (8–10.5 Hz), alpha 2 (10.5–
13 Hz), beta 1 (13–20 Hz), and beta 2 (20–30 Hz), in
continuity with a bulk of previous studies of this Con-
sortium on the cortical sources of resting EEG rhythms
in aging [22,27,37,67–69]. The choice of the fixed
EEG bands did not account for the IAF peak. However,
this should not affect the results, since more than 90%
of the subjects had the IAF peak within the alpha 1
band (8–10.5 Hz).
Cortical source of EEG rhythms as computed by
LORETA
LORETA software as provided at http://www.unizh.
ch/keyinst/NewLORETA/LORETA01.htm was used for
the estimation of cortical sources of EEG rhythms [70–
72]. LORETA is a functional imaging technique be-
longing to a family of linear inverse solution pro-
cedures [73] modeling 3D distributions of EEG
sources [72], which has been successfully used in re-
cent EEG studies on brain aging [18,22,67–69]. Of
note, here we preferred LORETA to its well known
evolution called standardized LORETA (sLORETA), to
have results fully comparable to those obtained by us-
ing LORETA in several previous studies of this Consor-
tium on eyes-closed resting state EEG rhythms along
pathological aging [27,28,38,67–69].
LORETA computes 3D linear solutions (LORETA
solutions) for the EEG inverse problem within a 3-shell
spherical head model including scalp, skull, and brain
compartments. The brain compartment is restricted to
the cortical gray matter/hippocampus of a head model
co-registered to the Talairach probability brain atlas and
digitized at the Brain Imaging Center of the Montreal
Table 3
Brodmann areas included in the cortical regions of inter-
est (ROIs) of the present study. LORETA solutions were
collapsed in frontal, central, parietal, occipital, temporal
ROIs
Loreta brodmann areas into the regions of interest (ROIs)
Frontal 8, 9, 10, 11, 44, 45, 46, 47
Central 1, 2, 3, 4, 6
Parietal 5, 7, 30, 39, 40, 43
Temporal 20, 21, 22, 37, 38, 41, 42
Occipital 17, 18, 19
Neurological Institute [74]. This compartment includes
2394 voxels (7 mm × 7 mm × 7 mm), each voxel
containing an equivalent current dipole. Therefore, the
theoretical spatial resolution of LORETA brain source
volume is of 7 mm. However, the real spatial resolution
is much lower for the following reasons.
LORETA solutions consisted of voxel current densi-
ty values able to predict EEG spectral power density at
scalp electrodes, independently of the electrode refer-
ence used. These solutions were normalized by divid-
ing the LORETA current density values at each vox-
el for the power density value obtained averaging the
LORETA current density values across all frequencies
(0.5–45 Hz) and all 2394 voxels of the brain volume.
After the normalization, the solutions lost the original
physical dimension and were represented by an arbi-
trary unit scale (for sake of brevity and clarity, we ref-
ereed to this scale as LORETA current density). This
procedure reduced inter-subjects variability and fitted
the LORETA solutions in a Gaussian distribution [75,
76].
These solutions of the EEG inverse problem are
under-determined and ill conditioned, since the number
of spatial samples (electrodes) is lower than that of the
unknown variables estimated by solving the EEG in-
verse problem (current density at each voxel). In order
to properly address this problem, the cortical LORETA
solutions predicting scalp EEG spectral power densi-
ty were regularized to estimate distributed rather than
punctual EEG source patterns [70–72]; this blurring
regularization reduced the theoretical spatial resolution
of the source estimation to centimeters. To further take
into account the low spatial resolution of the LORE-
TA solutions, we used our MATLAB software to col-
lapse the voxels of LORETA solutions at frontal, cen-
tral, parietal, occipital, temporal, and limbic regions
of the brain model coded into Talairach space. The
Brodmann areas listed in Table 3 formed each of these
regions of interest (ROIs). On the whole, the proce-
dures and transformations of the present methodologi-
cal approach produced a putative spatial resolution of
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several centimeters, corresponding to the spatial differ-
ence among the epicenters of the mentioned cortical
macroregions of interests. Such a low spatial resolution
made it marginal the fact that here the EEG electrode
positions were not co-registered to brain source models
based on individual magnetic resonance imaging. We
could not perform this co-registration, since the offi-
cial LORETA package does not support the integration
of the electrode positions and individual brain sources.
As a main advantage, the use of the official LORE-
TA package ideally allows to all EEG research units to
replicate the present results.
Statistical analysis of the LORETA solutions
Statistical analysis was performed by ANOVAs using
subjects’ age, education, gender, IAF, and MMSE as
covariates (p < 0.05). The Mauchly’s test evaluated
the sphericity assumption. Correction of the degrees
of freedom was made with the Greenhouse–Geisser
procedure. The Duncan test was used for the post-hoc
testing (p < 0.05).
To evaluate the control hypothesis of differences in
Nold, MCI, and AD subjects as cortical sources of rest-
ing eyes-closed EEG rhythms, an ANOVA used the
following factors: Group (Nold, MCI, AD; indepen-
dent variable), Band (delta, theta, alpha 1, alpha 2, be-
ta 1, beta 2), and ROI (central, frontal, parietal, oc-
cipital, temporal). The existence of LORETA source
differences among the groups would be confirmed by a
statistical ANOVA effect including the factor Group.
The working hypothesis stated that Nold, MCI, and
AD subjects are expected to be characterized by a dif-
ferent “reactivity” to eye opening of cortical sources of
resting alpha rhythms. For a given frequency band, the
“reactivity” was defined as the power difference of re-
gional normalized LORETA solutions in the eyes-open
condition minus eyes-closed condition For example,
we computed the individual difference of the LORETA
solution for occipital alpha 1 region between eyes-open
condition and eyes-closed condition, and so on for the
other regions, frequency bands of interest, and indi-
viduals. Negative values of this difference indexed a
decrease of alpha power during the eyes opening. The
power difference was used as a dependent variable for
an ANOVA having the factors Group (Nold, MCI and
AD; independent variable), Band (delta, theta, alpha 1,
alpha 2, beta 1, beta 2), and ROI (central, frontal, pari-
etal, occipital, temporal). In this ANOVA, additional
covariates were the regional cortical sources of the rest-
ing eyes-closed alpha 1 and alpha 2 rhythms. The ex-
istence of LORETA alpha source differences between
the groups would be confirmed by a statistical ANOVA
effect including the factor Group.
Regional power differences of the normalized
LORETA solutions fitting the pattern of EEG power
suppression “Nold>MCI>AD” were evaluated as lin-
ear correlations with MMSE score in the MCI and AD
subjects as a whole group (Pearson correlation test;
Bonferroni corrected, p < 0.05), namely the grey zone
in the continuum between preclinical and clinical stages
of the disease.
RESULTS
Comparison of cortical sources of resting state
eyes-closed EEG rhythms
The Nold group presented alpha 1 sources with the
maximal values of amplitude distributed in parieto-
occipital regions. Delta, theta, and alpha 2 sources had
moderate amplitude values when compared to alpha 1
sources. Finally, beta 1 and beta 2 sources were char-
acterized by lowest amplitude values. Compared to the
Nold group, the MCI group showed a decrease in ampli-
tude of parietal, occipital, and temporal alpha sources.
With respect to the Nold and MCI groups, the AD group
showed an amplitude increase of widespread delta and
theta sources, along with a strong amplitude reduction
of parietal, occipital, and temporal alpha sources.
An ANOVA was used to test the control hypoth-
esis that the above differences were statistically sig-
nificant (p < 0.05). Indeed, there was a statistical-
ly significant ANOVA interaction (F(40,3100) = 4.67;
p < 0.001) among the factors Group (AD, MCI, Nold),
Band (delta, theta, alpha 1, alpha 2, beta 1, beta 2),
and ROI (central, frontal, parietal, occipital, temporal),
with age, education, gender, IAF, and MMSE as co-
variates. In line with the control hypothesis, some EEG
sources showed different amplitude across Nold, MCI,
and AD subjects: namely, delta sources in frontal and
temporal areas, alpha 1 sources in parietal, and occip-
ital areas (p < 0.001), and alpha 2 sources in parietal,
and occipital areas (p < 0.005 to 0.001). These re-
sults were globally in line with previous evidence [38,
67–69].
Reactivity of resting alpha EEG rhythms
For illustrative purposes, Fig. 1 plots the grand av-
erage of the LORETA solutions (i.e., normalized pow-
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Fig. 1. Grand average of the LORETA solutions (i.e., relative power current density at cortical voxels) modeling the distributed EEG cortical
sources at delta, theta, alpha 1, alpha 2, beta 1, and beta 2 bands in MCI and AD subjects for the two conditions, namely eyes-closed and
eyes-open. The left side of the maps (top view) corresponds to the left hemisphere. Legend: LORETA, low resolution brain electromagnetic
tomography. Color scale: all power density estimates were scaled based on the averaged maximum value (i.e., alpha 1 power value of occipital
region in MCI eyes-closed). The maximal value of power density is reported under the figure. (Colors are visible in the electronic version of this
article at http://dx.doi.org/10.3233/JAD-2010-100798)
er current density at cortical voxels) modeling the dis-
tributed EEG cortical sources for delta, theta, alpha 1,
alpha 2, beta 1, and beta 2 bands in the MCI and AD
subjects. These solutions refer to the eyes-closed and
eyes-open conditions. In both MCI and AD groups,
the cortical sources of alpha 1 and alpha 2 were low-
er in amplitude in the eyes-open than eyes-closed con-
dition, as an effect of the reactivity of cortical neural
synchronization to the eyes-open condition. An oppo-
site effect was observed in cortical delta sources. For
control purposes, Fig. 2 plots the power difference of
regional absolute LORETA solutions in the eyes-open
minus eyes-closed condition modeling the distributed
EEG cortical sources for delta, theta, alpha 1, alpha 2,
beta 1, and beta 2 bands in the MCI and AD subjects.
The figure shows a similar trend with respect to the
normalized LORETA sources.
To test the statistical significance of these differ-
ences of the normalized LORETA solutions, an ANO-
VA was used (age, education, gender, IAF, MMSE,
and resting eyes-closed alpha rhythms as covariates;
p < 0.05). Figure 3 shows the power difference of re-
gional normalized LORETA solutions in the eyes-open
minus eyes-closed condition (i.e., “reactivity”) rela-
tive to a statistical ANOVA interaction (F(40,3100) =
3.75; p < 0.001) among the factors Group (AD, MCI,
Nold), Band (delta, theta, alpha 1, alpha 2, beta 1,
beta 2), and ROI (central, frontal, parietal, occipital,
temporal). The planned post-hoc testing showed that
the EEG source suppression pattern Nold>MCI>AD
was fitted by the following normalized regional LORE-
TA solutions: parietal, occipital, and temporal alpha 1
sources (p < 0.001) as well as parietal and occipital
alpha 2 sources (p < 0.05 to 0.001). These results
were confirmed by a control ANOVA analysis prob-
ing LORETA solutions for each ROI considered sep-
arately (central, frontal, parietal, occipital, temporal).
Again, the source pattern Nold>MCI>AD was fitted
by the following 3 normalized regional LORETA so-
lutions: parietal (F(10,775) = 2.89; p < 0.005), oc-
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Fig. 2. Absolute source values of the LORETA solutions (eyes-open minus eyes-closed) in MCI and AD subjects for the delta, theta, alpha 1,
alpha 2, beta 1, and beta 2 bands. (Colors are visible in the electronic version of this article at http://dx.doi.org/10.3233/JAD-2010-100798)
cipital (F(10,775) = 4.55; p < 0.001), and temporal
(F(10,775) = 3.28; p < 0.001) alpha 1 sources. Pari-
etal and occipital alpha 2 sources just fitted the EEG
source suppression pattern AD and MCI < Nold.
The amplitude of the above statistically significant
alpha 1 and alpha 2 source power differences (i.e., re-
activity to eyes-open condition; p < 0.05 to 0.001) was
correlated with the MMSE score in the MCI and AD
subjects as a whole group (Pearson test, p < 0.05).
Bonferroni correction for the five repetitions of the test
set the statistical threshold to p < 0.01 to obtain the
Bonferroni corrected p < 0.05. The MMSE score neg-
atively correlated (r = −0.24, p = 0.01) with occipital
alpha 1 source power difference (Fig. 4); the higher the
MMSE score, the higher the source power difference
as expressed by negative values. No statistically sig-
nificant correlation was observed (p > 0.01) between
the MMSE and the remaining alpha power source dif-
ferences at parietal and temporal alpha 1 as well as at
parietal and occipital alpha 2.
Control analyses
We performed some control analyses to ascertain if
the results of the main statistical analysis were affected
by relevant confounding variables.
In a first control analysis, we performed a correla-
tion between the resting state eyes closed alpha pow-
er showing the pattern Nold>MCI>AD and the alpha
reactivity to eyes opening (Pearson’s test; p < 0.05),
in order to evaluate the relationships between the cor-
tical neural synchronization/desynchronization in the
two conditions. The results showed a statistically sig-
nificant correlation for parietal, occipital, and temporal
alpha 1 sources as well as for parietal and occipital al-
pha 2 sources (r = from −0.83 to −0.95, p < 0.001).
The higher the eyes closed alpha power, the higher the
alpha reactivity to eyes opening. Of note, this correla-
tion was quite high but unable to entirely explain the
pattern Nold>MCI>AD of the alpha reactivity to eyes
opening. Indeed, we obtained significant inter-groups
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Fig. 3. Normalized power differences at the regional normalized LORETA solutions (eyes-open minus eyes-closed) relative to a statistical
ANOVA interaction (F(40,3100) = 3.75; p < 0.001) among the factors Group (AD, MCI, Nold), Band (delta, theta, alpha 1, alpha 2, beta 1,
beta 2), and ROI (central, frontal, parietal, occipital, temporal). Subjects’ age, education, gender, IAF, MMSE and resting alpha Loreta Current
Density eyes closed were used as covariates. The planned post-hoc testing showed that the source pattern eyes-closed > eyes-open was fitted
by the following 5 normalized regional LORETA solutions: parietal, occipital and temporal alpha 1 sources (p < 0.005 to 0.001) as well as
parietal and occipital alpha 2 sources (p < 0.05 to 0.001). Legend: the rectangles indicate the cortical regions and frequency bands in which
LORETA solutions presented statistically significant LORETA patterns (p < 0.05). (Colors are visible in the electronic version of this article at
http://dx.doi.org/10.3233/JAD-2010-100798)
effects of alpha reactivity to eyes opening although rest-
ing state eyes closed alpha power at relevant sources
was used as a covariate in the statistical model.
In a second control analysis, we performed an ANO-
VA using the power difference of regional absolute
(as opposed to normalized) LORETA solutions in the
eyes-open minus eyes-closed condition as a dependent
variable. The ANOVA factors were Group (AD, MCI,
Nold), Band (delta, theta, alpha 1, alpha 2, beta 1,
beta 2), and ROI (central, frontal, parietal, occipital,
temporal). Subjects’ age, education, gender, IAF, and
MMSE served as covariates. In contrast to the ANOVA
using the regional relative LORETA solutions, the con-
trol analysis showed no statistically significant interac-
tion among the factors (p > 0.05). These control results
confirmed that with respect to relative EEG power, ab-
solute EEG power depends on (irrelevant) properties of
conductibility of subjects’ skull, and may be less sensi-
tive to the changes due to brain neural synchronization.
In a third control analysis, we performed an ANO-
VA using the LORETA solutions relative to a low-
frequency alpha sub-band of 7–9 Hz in the eyes-open
minus eyes-closed condition as a dependent variable.
This sub-band was lower than mean IAF (i.e., around
9 Hz), to control that the results were not affected
by high alpha frequencies. The ANOVA factors were
Group (AD, MCI, Nold) and ROI (central, frontal, pari-
etal, occipital, temporal). Subjects’ age, education,
gender, IAF, and MMSE served as covariates. There
was a statistically significant interaction between the
factors (F(8,620) = 2.39; p < 0.01). Post-hoc testing
indicated that parietal, occipital and temporal alpha re-
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Fig. 4. Scatter plots relative to the results of a correlation analysis between MMSE and occipital alpha 1 sources of EEG rhythms (eyes-open
minus eyes-closed) in the MCI and AD subjects as a whole group. (Colors are visible in the electronic version of this article at http://dx.doi.
org/10.3233/JAD-2010-100798)
activity to the eyes opening showed differences among
the AD and the Nold and MCI subjects (p < 0.01), in
line with the results of the main statistical analysis.
In a fourth control analysis, we performed an ANO-
VA including sub-groups of subjects that were careful-
ly matched as number (31 AD, 31 MCI, and 31 Nold
subjects), mean age (AD = 70.5 years; MCI = 70.2
years; Nold = 66.0 years), and mean education (AD =
6.5, MCI = 6.7, and Nold = 7.3 years). This allowed a
good control of the inter-groups variability. The depen-
dent variable was the normalized LORETA solution in
eyes-open minus eyes-closed condition. The ANOVA
design was the same of the main analysis. There was a
statistical ANOVA interaction (F(40,1800)= 3.68; p <
0.0001) among the factors Group (AD, MCI, Nold),
Band (delta, theta, alpha 1, alpha 2, beta 1, beta 2),
and ROI (central, frontal, parietal, occipital, temporal).
The planned post-hoc testing substantially confirmed
the results of the main analysis, showing that the EEG
source suppression pattern Nold>MCI>AD was fit-
ted by parietal, occipital, and temporal alpha 1 sources
(p < 0.05).
In a fifth control analysis, we performed a control
data analysis to cross-validate the present LORETA re-
sults with an analysis of EEG spectral power density
computed at the scalp electrodes. We strictly followed
the general methodological approach used for the anal-
ysis of the LORETA solutions. The EEG spectral pow-
er density at each electrode was normalized to the EEG
spectral power density averaged across all frequencies
(0.5–45 Hz) and the electrodes, which were represen-
tative of the following scalp regions: (i) Fp1, Fp2, F7,
F3, Fz, F4, and F8 electrodes for the frontal region;
(ii) C3, Cz and C4 electrodes for the central region;
(iii) P3, Pz and P4 electrodes for the parietal region;
(iv) T3, T4, T5, and T6 electrodes for the temporal
region; (v) O1 and O2 electrodes for the occipital re-
gion. For a given region, the regional power density
for the eyes-closed (eyes-open) condition was defined
as the power density averaged across all electrodes of
that region. The reactivity of regional EEG power den-
sity to the eyes opening and the statistical comparisons
were computed according to the procedures used for
the analysis of the LORETA solutions. The relative
ANOVA used the power difference of regional scalp
solutions in the eyes-open minus eyes-closed condition
as a dependent variable. The ANOVA factors were
Group (AD, MCI, Nold), Band (delta, theta, alpha 1,
alpha 2, beta 1, beta 2), and Scalp ROI (central, frontal,
parietal, occipital, temporal). Subjects’ age, education,
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gender, IAF, and MMSE served as covariates. Results
showed a statistical ANOVA interaction (F(40,3100) =
7.14; p < 0.001) among the factors Group (AD, MCI,
Nold), Band (delta, theta, alpha 1, alpha 2, beta 1, be-
ta 2), and Scalp ROI (central, frontal, parietal, occipital,
temporal). The planned post-hoc testing showed that
the scalp EEG reactivity pattern Nold>MCI>AD was
fitted by the following normalized regional scalp solu-
tions: parietal, occipital, and temporal alpha 1 (p <
0.05 to 0.001) as well as parietal and occipital alpha 2
(p < 0.05 to 0.001). The amplitude of the above sta-
tistically significant alpha 1 and alpha 2 scalp solutions
(i.e., reactivity to eyes-open condition; p < 0.05 to
0.001) was correlated with the MMSE score in the MCI
and AD subjects as a whole group (Pearson test, p <
0.05). Bonferroni correction for the 5 repetitions of the
test set the statistical threshold to p < 0.01 to obtain the
Bonferroni corrected p < 0.05. No statistically signif-
icant correlation was observed (p > 0.01) between the
MMSE and the mentioned alpha scalp solutions in the
MCI and AD subjects as a whole. Summarizing, the
results showed that in good accordance with the LORE-
TA solutions reported above, posterior scalp alpha reac-
tivity to the eyes opening showed differences between
the Nold and MCI subjects and between the MCI and
AD subjects. However, in contrast with the LORETA
solutions reported above, the occipital scalp alpha 1
reactivity was not correlated to the MMSE score.
DISCUSSION
This study tested the hypothesis of a progressive im-
pairment of cortical alpha reactivity to the eyes-open
compared with eyes-closed condition across Nold, am-
nesic MCI and AD subjects, reflecting the functional
impairment of cortical neural desynchronization in the
grey zone of the continuum between preclinical and
clinical stages of AD. This issue represents the step for-
ward of the present study with respect to previous stud-
ies of this Consortium (i.e., Authors’ research groups)
focused on the mechanisms of cortical neural synchro-
nization associated to the condition of eyes closed rest-
ing state [27,28,38,67,68]. With respect to the EEG
literature [30,33,36] the novelty of the present EEG
study is to focus on topographical reactivity of alpha
rhythms to eyes opening and to use relatively large
groups of Nold, amnesic MCI, and mild AD subjects,
to better take into account for head volume conduction
effects and inter-groups variability of resting state EEG
rhythms.
In the control eye-closed condition, posterior corti-
cal sources of alpha rhythms were lower in power in
the MCI and AD subjects than in the normal elderly
subjects. Furthermore, the opposite was true for frontal
and temporal cortical sources of delta rhythms. These
control results were in line with previous EEG evidence
of our Consortium showing progressive differences of
resting eyes-closed cortical alpha rhythms along the
shadow line across Nold, amnesic MCI, and mild AD
subjects [27,28,38,67,68].
With respect to the eyes-closed condition, the eyes-
open condition induced a suppression of posterior alpha
sources that was greater in the Nold than MCI subjects
and in the MCI than AD subjects. In the occipital low-
frequency alpha sources, this reactivity was proportion-
al to the subjects’ global cognitive function as revealed
by MMSE score across MCI and AD individuals (i.e.,
the grey zone of the disease).
Notably, the eyes-closed alpha power and alpha reac-
tivity to eyes opening pointed to a remarkable correla-
tion and to a similar source pattern in the MCI and AD
subjects. However, these variables provided at least in
part independent physiological information, since the
inter-groups differences in alpha reactivity were still
significant when the eyes closed alpha sources were
used as covariate in the statistical model. On the whole,
it can be speculated that the synchronizing neural cir-
cuits at the basis of eyes closed alpha rhythms largely
corresponded to the neural circuits that desynchronized
during eyes opening.
The present results agree with previous EEG and
MEG studies showing that alpha power during eye
opening is suppressed more in Nold than in AD sub-
jects, as a reflection of impaired cortical neural desyn-
chronization in visual systems of the patients [21,31–
33,35,36]. They also agree with previous sugges-
tion that alpha reactivity to eye opening might predict
the deterioration of higher functions in subjects with
cognitive decline [33]. Since some of previous EEG
and MEG studies have shown that differences between
MCI and AD subjects at resting state are not ever dis-
cernible [30,33,36], we suggest that ideally, EEG and
MEG techniques are used in a combined way to better
understand neurophysiology of brain rhythms in am-
nesic MCI and AD subjects for basic research and clin-
ical applications. High spatial resolution MEG tech-
niques would be effective in the fine topographical esti-
mation of tangentially-oriented cortical sources of brain
rhythms, while the present low-resolution EEG ap-
proach would be sensitive to the global activity of both
tangentially- and radially-oriented cortical sources. Of
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course, this scenario may come true when MEG tech-
nology could be largely accessible, and automation of
the data analysis procedures could reduce time and
costs for the production of clinical reports.
An open issue of the present study is whether
the present methodological approach for the evalu-
ation of resting state EEG rhythms be used alone
for personalized diagnosis and prognosis of individual
MCI subjects, given the intrinsic variability of alpha
rhythms [30,77]. We think that the present method-
ological approach is promising for future clinical ap-
plications. Indeed, it represents a simple, quick and
cheap experimental model to probe the relationships
between aging and mechanisms of cortical neural syn-
chronization/desynchronization in two complementary
modes of resting state (i.e., presence/absence of visual
stimulus processing), without the confounding effects
of anxiety, fatigue, boring, and task complexity. In-
deed, these mechanisms reflect the integrity of neural
populations and synapses as well as the efficiency of
functional connectivity and brain reactivity. Such ex-
perimental model can be used with elderly individuals
ranging from full cognitive performance to severe cog-
nitive impairment, and is not affected by meta-learning
and effects of the repetition of the experimental record-
ings over time. The present results suggest that at least
at group level, AD progression is related to an impaired
reactivity of the mechanisms desynchronizing posteri-
or cortical neurons at alpha rhythms during eyes open-
ing. This conclusion represents a first important step
for understanding the relationship between early stages
of AD neurodegeneration and mechanisms of cortical
neural synchronization/desynchronization. It also rep-
resents an important motivation to ascertain the clini-
cal relevance of the present results (i.e., early diagno-
sis, prognosis, therapy monitoring) by future longitu-
dinal studies. In this regard, we are aware that the high
intrinsic inter-subjects variability of EEG reactivity to
eyes opening might prevent its practical clinical use for
early diagnosis/prognosis of AD in single MCI indi-
viduals. However, we think that there are promising
perspectives for the combined used of this EEG marker
together with other EEG (i.e., resting state eyes closed),
neuroimaging (MRI, PET-FDG, MEG), and biological
(CSF, blood) markers. Of special interest the coreg-
istration of resting state EEG rhythms and functional
MRI (fMRI). fMRI reflects the ratio between deoxy-
hemoglobin and oxyhemoglobin blood (BOLD), has a
low temporal resolution (> 1 s) and a very high spa-
tial resolution (< 1 cm), and is especially suitable to
investigate spatial details of both cortical and subcorti-
cal activation [78]. The resting state fMRI represents
an indirect measurement of the functional connectivity
among brain regions, and perfectly complements the
properties of resting state EEG rhythms [79].
A crucial question is then: “What is the function-
al meaning of a reduced alpha reactivity to eye open-
ing along MCI and AD subjects?” During slow-wave
sleep, corticofugal slow oscillations (< 1 Hz) are effec-
tive in grouping thalamic-generated delta rhythms (1–
4 Hz) and spindling activity (7–14 Hz) rhythms [80].
Delta would dominate EEG rhythms and alpha (about
8–12 Hz) would be low in amplitude. In the case of
brain arousal, spindles, high and low components of the
delta rhythms are blocked by the inhibition of reticulo-
thalamic (7–14 Hz), thalamo-cortical (1–4 Hz), and in-
tracortical (< 1 Hz) oscillators. These rhythms are re-
placed by fast oscillations (beta and gamma) induced
by forebrain (nucleus basalis) cholinergic inputs to hip-
pocampus and cortex as well as by thalamocortical pro-
jections [80,81]. In the condition of waking rest, 8–
10 Hz alpha oscillations represent the dominant resting
rhythms of human brain [82–85], and have been linked
to intelligence quotient, memory, and cognition [66].
Alpha rhythms are mainly generated by the coordinat-
ed interplay between cortico-cortical and thalamocor-
tical dynamics, as suggested by studies in higher mam-
mals (lower mammals show negligible or absent alpha
rhythms; for a review see [86]. Given that primary
visual cortex seems not to be seriously affected in the
prodromal stages of AD, it can be speculated that the
link between the present results (impairment of corti-
cal desynchronization mechanisms underlying EEG al-
pha reactivity) and neuropathological events or lesions
characterizing AD may rely upon abnormal postsynap-
tic potentials generated in large pyramidal neurons of
occipital-parietal cortical regions and in the neurons
conveying signals from parietal nodes of attention net-
works to visual cortex. This may be due to synap-
tic and neural loss associated to AD neurodegenerative
processes occurring initially and predominantly in the
medial temporal lobe structures including hippocam-
pus and amygdala [13]. Hippocampal and amygdalar
atrophy in AD have been documented, although thala-
mic degeneration in the early stages of the disease is
an open issue [13,87–90]. The hippocampus connects
directly with the anterior thalamus via the fornix and
mammillary bodies as well as with the pulvinar via the
temporopulvinar tract. Integrity of these connections is
essential for episodic memory [91], which is specifical-
ly impaired in AD [92]. Keeping in mind this premises,
it should be methodologically remarked that estimation
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of EEG sources by LORETA directly modeled cortical
but not thalamic generators of alpha rhythms. Indeed,
LORETA software uses dipole source into a volume
fitting cortical grey matter but not thalamus, basal gan-
glia and other sub-cortical structures. Therefore, cor-
tical sources of alpha rhythms can be affected by al-
tered inputs from thalamus but LORETA is not able to
directly model thalamic abnormalities. An abnormal
interplay between human thalamic and cortical neural
populations can be investigated by combined record-
ings of EEG and PET-FDG or fMRI. To this regard, it
has been shown that alpha power is positively correlat-
ed with the cerebral blood flow, glucose metabolism,
and BOLD signals in the thalamus, whereas it is neg-
atively correlated with these measurements in visual
areas [93–96].
In this theoretical framework, the role of choliner-
gic systems is still poorly known. On one hand, there
is no evidence of the participation of the basal fore-
brain, via its cholinergic innervation to the cortex, in
the generation of alpha rhythms in higher mammals. In
cholinergic basal forebrain, lesion and stimulation of
nucleus basalis of Meynert mainly affect fast cortical
oscillations in the range of gamma rhythms [97]. Fur-
thermore, human occipital cortex (peristriate areas, BA
19) receives a relatively scarce density of cholinergic
axons from the intermediate Ch4 subdivision [98]. On
the other hand, it has been emphasized the role of par-
allel cholinergic tracts from basal forebrain to human
hippocampus-amygdala, thalamus, and cerebral cortex
in the selection/modulation of cortical excitability for
attention and visual processes and consciousness [99,
100], which are typically related to alpha rhythms [66].
These cholinergic tracts would be targeted by AD neu-
rodegenerative processes [101–105], especially in AD
patients not responding to long term cholinergic thera-
py [106]. Instead, brainstem cholinergic innervation of
the thalamus would be relatively spared [103,107–110].
Furthermore it has been reported that scopolamine (a
cholinergic antagonist) mimicked in healthy subjects
the typical pattern of alpha and theta rhythms observed
in AD patients [77], and the loss of cholinergic con-
nections to cerebral cortex has been shown to reduce
the power of resting posterior alpha sources in amnesic
MCI subjects [111,112]. Moreover, it has been shown
that posterior sources of resting delta and alpha rhythms
were especially impaired in AD patients not respond-
ing to cholinergic therapy at 1-year follow up [113].
Finally, recent MEG data have pointed to a complex
interaction of several resting state EEG rhythms as the
reflection of the balance of different neuromodulation
systems [114].
Keeping in mind these data, progressive impair-
ment of the alpha reactivity to eye opening in the con-
tinuum along amnesic MCI and mild AD conditions
might reflect the synaptic and neural loss of large cor-
tical pyramidal neurons including those convey sig-
nals through white-matter to visual cortex, in order to
modulate arousal-attention and, hence, the transmis-
sion and processing of information [115,116]. Fu-
ture studies should clarify the role played by choliner-
gic, monoaminergic and glutamatergic systems in the
modulation of cortical excitability and alpha rhythms
in amnesic MCI and AD subjects [117,118]. In this
framework, an intriguing working hypothesis for these
future studies is that cholinergic systems play a re-
markable role in the desynchronization of posterior al-
pha rhythms during eyes opening (and mental activity),
whereas cortico-cortical and thalamo-cortical interac-
tions rhythms play a remarkable role in the synchro-
nization of posterior alpha rhythms in the condition of
eyes closed resting state.
In conclusion, the novelty of present study was to test
the hypothesis of a progressive impairment of cortical
alpha reactivity to eye opening among relatively large
groups of Nold, amnesic MCI and AD subjects, pos-
sibly reflecting the functional impairment of cortical
neural desynchronization in the grey zone between pre-
clinical and clinical stages of AD. Compared with the
eyes–closed condition, the eyes-open condition showed
a power reduction of posterior alpha 1 and 2 sources
that was greater in the Nold than in MCI subjects and
in the MCI than AD subjects. In the occipital alpha 1
sources, this reduction was proportional to the subjects’
global cognitive function as revealed by MMSE score
across MCI and AD individuals. The present results
suggest that at least in its early stages and at group lev-
el, AD progression is related to an impaired reactivity
of the mechanisms desynchronizing cortical neurons at
alpha rhythms during background visual information
processing. This conclusion represents a first impor-
tant step for understanding the relationship between
early stages of AD neurodegeneration and mechanisms
of cortical neural desynchronization as a reflection of
functional brain connectivity and physiological reac-
tivity. However, despite their important heuristic value,
the present results are valid at group level and are not
conclusive about the utility of the present methodologi-
cal approach for diagnostic/prognostic purposes in sin-
gle amnesic MCI subjects. Future longitudinal “follow
up” studies should evaluate the clinical relevance of the
present results towards practical clinical applications.
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